Title : A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD.

Pub. Date : 2002 Apr

PMID : 11918754






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This double-blind randomized study investigated the efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, atorvastatin, in continuous ambulatory peritoneal dialysis (CAPD) patients with dyslipidemia. Atorvastatin 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens